- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Ulipristal – July 2016
Ulipristal: 5 mg tablet, 28, Esmya®
Last updated
11 November 2016